Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer

Journal of Clinical Oncology

Volumn 21, Issue 18, 2003, Pages 3469-3478

  Wiedswang, Gro ^a   Borgen, E ^a   Karesen R ^a   Kvalheim, G ^a   Nesland, J M ^a   Qvist, H ^a   Schlichting, E ^a   Sauer, T ^a   Janbu, J ^a   Harbitz, T ^a   Naume, B ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN; CATHEPSIN D; CYTOKERATIN ANTIBODY; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; PROTEIN P53; THYROID HORMONE RECEPTOR BETA;

ARTICLE; BONE MARROW CELL; BREAST CANCER; CELL ISOLATION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR CELL; TUMOR VOLUME; BONE MARROW; BREAST TUMOR; CLINICAL TRIAL; FEMALE; LYMPH NODE METASTASIS; METASTASIS; MORTALITY; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; NEEDLE BIOPSY; PATHOLOGY; SURVIVAL RATE; TUMOR RECURRENCE;

BIOPSY, NEEDLE; BONE MARROW; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; SURVIVAL RATE;

EID: 0142026060     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.02.009     Document Type: Article

References (28)

1. Early Breast Cancer Trialists' Collaborative Group: Polychemotherapy for early breast cancer: An overview of the randomised trials. Lancet 352:930-942, 1998
2. Early Breast Cancer Trialists' Collaborative Group: Tamoxifen for early breast cancer: An overview of the randomised trials. Lancet 351:1451-1467, 1998
3. Cote RJ, Rosen PP, Lesser ML, et al: Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J Clin Oncol 9:1749-1756, 1991
4. Diel IJ, Kaufmann M, Costa SD, et al: Micrometastatic breast cancer cells in bone marrow at primary surgery: Prognostic value in comparison with nodal status. J Natl Cancer Inst 88:1652-1658, 1996
5. Braun S, Pantel K, Muller P, et al: Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N Engl J Med 342:525-533, 2000
6. Mansi JL, Berger U, Easton D, et al: Micrometastases in bone marrow in patients with primary breast cancer: Evaluation as an early predictor of bone metastases. BMJ 295:1093-1096, 1987
7. Harbeck N, Untch M, Fache L, et al: Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: Results of a 3-year median follow-up. Br J Cancer 69:566-571, 1994
8. Gebauer G, Fehm T, Merkle E, et al: Epithelial cells in bone marrow of breast cancer patients at time of primary surgery: Clinical outcome during long-term follow-up. J Clin Oncol 19:3669-3674, 2001
9. Funke I, Schraut W: Meta-analyses of studies on bone marrow micrometastases: An independent prognostic impact remains to be substantiated. J Clin Oncol 16:557-566, 1998
10. Mansi JL, Gogas H, Bliss JM, et al: Outcome of primary-breast-cancer patients with micrometastases: A long-term follow-up study. Lancet 354:197-202, 1999
11. Braun S, Pantel K: Prognostic significance of micrometastatic bone marrow involvement. Breast Cancer Res Treat 52:201-216, 1998
12. Borgen E, Naume B, Nesland JM, et al: Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. Establishment of objective criteria for the evaluation of immunostained cells. Cytotherapy 1:377-388, 1998
13. Naume B, Borgen E, Kvalheim G, et al: Detection of isolated tumor cells in bone marrow in early-stage breast carcinoma patients: Comparison with preoperative clinical parameters and primary tumor characteristics. Clin Cancer Res 7:4122-4129, 2001
14. Naume B, Borgen E, Nesland JM, et al: Increased sensitivity for detection of micrometastases in bone- marrow/peripheral-blood stem-cell products from breast-cancer patients by negative immunomagnetic separation. Int J Cancer 78:556-560, 1998
15. Elston CW, Ellis IO: Pathological prognostic factors in breast cancer: I. The value of histological grade in breast cancer-Experience from a large study with long-term follow-up. Histopathology 19:403-410, 1991
16. Wiedswang G, Borgen E, Kåresen R, et al: Detection of isolated tumour cells in bone marrow from breast cancer patients: The significance of anterior and posterior iliac crest aspirations and the number of mononuclear cells analysed. Cytotherapy 5:40-45, 2003
17. Braun S, Schlimok G, Heumos I, et al: ErbB2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patients. Cancer Res 61:1890-1895, 2001
18. Heiss MM, Allgayer H, Gruetzner KU, et al: Individual development and uPA-receptor expression of disseminated tumour cells in bone marrow: A reference to early systemic disease in solid cancer. Nat Med 1:1035-1039, 1995
19. Pantel K, Cote RJ, Fodstad O: Detection and clinical importance of micrometastatic disease. J Natl Cancer Inst 91:1113-1124, 1999
20. Klein CA, Blankenstein TJF, Schmidt-Kittler O, et al: Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer. Lancet 360:683-689, 2002
21. Offner S, Schmaus W, Witter K, et al: p53 gene mutations are not required for early dissemination of cancer cells. Proc Natl Acad Sci USA 96:6942-6946, 1999
22. Mehes G, Witt A, Kubista E, et al: Circulating breast cancer cells are frequently apoptotic. Am J Pathol 159:17-20, 2001
23. Pantel K, Schlimok G, Braun S, et al: Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells. J Natl Cancer Inst 85:1419-1424, 1993
24. Sorlie T, Perou CM, Tibshirani R, et al: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98:10869-10874, 2001
25. Perou CM, Sorlie T, Eisen MB, et al: Molecular portraits of human breast tumours. Nature 406:747-752, 2000
26. van't-Veer LJ, Dai H, van de Vijver MJ, et al: Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530-536, 2002
27. Braun S, Kentenich C, Janni W, et al: Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients. J Clin Oncol 18:80-86, 2000
28. Janni W, Hepp F, Rjosk D, et al: The fate and prognostic value of occult metastatic cells in the bone marrow of patients with breast carcinoma between primary treatment and recurrence. Cancer 92:46-53, 2001